Compounds > poloxalene
Page last updated: 2024-08-22

poloxalene and Prostatic Neoplasms

poloxalene has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Başak Türkmen, N; Beker, MÇ; Çağlayan, AB; Dede, B; Demirci, S; Doğan, A; Kiliç, E; Özkan, F; Şahin, F; Telci, D1
Demirci, S; Doğan, A; Rizvanov, AA; Şahin, F; Telci, D; Türkmen, NB1

Other Studies

2 other study(ies) available for poloxalene and Prostatic Neoplasms

ArticleYear
Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo.
    Anti-cancer drugs, 2017, Volume: 28, Issue:8

    Topics: Animals; Cell Line, Tumor; Coordination Complexes; Gene Expression; Humans; Male; Mice, Inbred C57BL; Poloxalene; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Schiff Bases

2017
Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 86

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice; Poloxalene; Poloxamer; Polyethylene Glycols; Prostatic Neoplasms; Schiff Bases

2017